EU Decision Time For Insmed’s Brensocatib And Sanofi’s Belumosudil

 
• By Eliza Slawther
  
Hand push red Red Cross mark to choose cancellation item , Approve and reject business and document
The European Medicines Agency's CHMP could back several new products for pan-EU approval this month (Shutterstock)

More from EU CHMP

More from Europe